Connect with us


New COVID treatment shows efficacy against omicron: Spain’s PharmaMar

Spain's PharmaMar said on Tuesday trials made in vitro and on animals showed its Plitidepsin drug had positive antiviral effects on the variants of COVID-19, including omicron.

The results of Phase I trials have shown the drug, also known as Aplidin, had a powerful antiviral activity against all the variants in vitro and a distribution into the lungs of animals tested, resulting in a 99 percent reduction of viral load in the lungs, the company said.

For more coronavirus news, visit our dedicated page.

The results of the trials were released in a paper published in the scientific journal Life Science Alliance, PharmaMar said.

The paper also reported positive effects of Phase I and II trials on patients.

"All data we have seen so far with Plitidepsin corroborate our initial hypothesis of its activity as antiviral," PharmaMar's Jose Maria Fernandez Sousa said in a statement.

The drug is being tested in final Phase III trials on patients.

Shares in PharmaMar rose 5.3 percent in early trading.

Plitidepsin is a drug developed by PharmaMar originally to treat cancer but has an effect as an antiviral.

Read more:

Bulgarian PM self-isolates after close COVID contact during security meeting

Poland’s total COVID-19 death toll passes 100,000 amid fourth wave

‘Deltacron’ likely result of lab error: Experts

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


WHO chief warns against misinformation over global pandemic accord

The head of the UN World Health Organization on Thursday spoke out forcefully against “misinformation on social media and in the mainstream media” which has falsely alleged that a new global pandemic accord being negotiated, would allow the WHO to override national sovereignty relating to a future outbreak.

Continue Reading


World Tuberculosis Day: WHO ramps up initiative to combat killer disease

For the first time in more than a decade, the number of people dying from tuberculosis (TB) rose last year due to disruptions caused by the COVID-19 pandemic, conflicts and other crises, the World Health Organization (WHO) said on Thursday.

Continue Reading


Tanzania confirms first-ever outbreak of deadly Marburg Virus Disease

Tanzania confirmed its first-ever cases of Marburg Virus Disease after conducting laboratory tests in the country’s northwest Kagera region, the World Health Organization (WHO) said in a statement on Wednesday.

Continue Reading